The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Traumatic Brain Injury Therapeutics Market Research Report 2025

Global Traumatic Brain Injury Therapeutics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1885394

No of Pages : 98

Synopsis
Traumatic brain injury (TBI) is a nondegenerative, noncongenital insult to the brain from an external mechanical force, possibly leading to permanent or temporary impairment of cognitive, physical, and psychosocial functions, with an associated diminished or altered state of consciousness.
Traumatic brain injuries are usually emergencies and consequences can worsen rapidly without treatment. Doctors usually need to assess the situation quickly. Fast acting and effective tests to detect TBI will reduce hospital CT scans (the only current way to diagnose a TBI) by up to a third.
The global Traumatic Brain Injury Therapeutics market was valued at US$ 923.3 million in 2023 and is anticipated to reach US$ 1184.3 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Traumatic Brain Injury Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Traumatic Brain Injury Therapeutics.
Report Scope
The Traumatic Brain Injury Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Traumatic Brain Injury Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Traumatic Brain Injury Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SFC Fluidics LLC
Banayan Biomarkers Inc.
BHR Pharma LLC
Cerora Inc.
ElMindA Ltd.
Grace Laboratories LLC
KeyNeurotek Pharmaceuticals AG
Luoxis Diagnostics
Neuro Assessment Systems
Neurovive Pharmaceuticals AB
Oxygen Biotherapeutics Inc.
Phlogistix LLC
Neurohealing Pharmaceuticals
Neuren Pharmaceuticals Ltd.
Remedy Pharmaceuticals Inc.
Biodirection Inc.
Brainscope Company Inc.
TEVA Pharmaceutical Industries Ltd.
Vasopharm
Segment by Type
Acetylcholinesterase Inhibitors
Erythropoietin
Growth Hormone
Stem Cells
Others
Segment by Application
Local TBI
Open TBI
Closed TBI
Diffuse TBI
Primary TBI
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Traumatic Brain Injury Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Traumatic Brain Injury Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Acetylcholinesterase Inhibitors
1.2.3 Erythropoietin
1.2.4 Growth Hormone
1.2.5 Stem Cells
1.2.6 Others
1.3 Market by Application
1.3.1 Global Traumatic Brain Injury Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Local TBI
1.3.3 Open TBI
1.3.4 Closed TBI
1.3.5 Diffuse TBI
1.3.6 Primary TBI
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Traumatic Brain Injury Therapeutics Market Perspective (2019-2030)
2.2 Traumatic Brain Injury Therapeutics Growth Trends by Region
2.2.1 Global Traumatic Brain Injury Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Traumatic Brain Injury Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Traumatic Brain Injury Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Traumatic Brain Injury Therapeutics Market Dynamics
2.3.1 Traumatic Brain Injury Therapeutics Industry Trends
2.3.2 Traumatic Brain Injury Therapeutics Market Drivers
2.3.3 Traumatic Brain Injury Therapeutics Market Challenges
2.3.4 Traumatic Brain Injury Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Traumatic Brain Injury Therapeutics Players by Revenue
3.1.1 Global Top Traumatic Brain Injury Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Traumatic Brain Injury Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Traumatic Brain Injury Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Traumatic Brain Injury Therapeutics Revenue
3.4 Global Traumatic Brain Injury Therapeutics Market Concentration Ratio
3.4.1 Global Traumatic Brain Injury Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Traumatic Brain Injury Therapeutics Revenue in 2023
3.5 Traumatic Brain Injury Therapeutics Key Players Head office and Area Served
3.6 Key Players Traumatic Brain Injury Therapeutics Product Solution and Service
3.7 Date of Enter into Traumatic Brain Injury Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Traumatic Brain Injury Therapeutics Breakdown Data by Type
4.1 Global Traumatic Brain Injury Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Traumatic Brain Injury Therapeutics Forecasted Market Size by Type (2025-2030)
5 Traumatic Brain Injury Therapeutics Breakdown Data by Application
5.1 Global Traumatic Brain Injury Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Traumatic Brain Injury Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Traumatic Brain Injury Therapeutics Market Size (2019-2030)
6.2 North America Traumatic Brain Injury Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Traumatic Brain Injury Therapeutics Market Size by Country (2019-2024)
6.4 North America Traumatic Brain Injury Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Traumatic Brain Injury Therapeutics Market Size (2019-2030)
7.2 Europe Traumatic Brain Injury Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Traumatic Brain Injury Therapeutics Market Size by Country (2019-2024)
7.4 Europe Traumatic Brain Injury Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Traumatic Brain Injury Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Traumatic Brain Injury Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Traumatic Brain Injury Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Traumatic Brain Injury Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Traumatic Brain Injury Therapeutics Market Size (2019-2030)
9.2 Latin America Traumatic Brain Injury Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Traumatic Brain Injury Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Traumatic Brain Injury Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Traumatic Brain Injury Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Traumatic Brain Injury Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SFC Fluidics LLC
11.1.1 SFC Fluidics LLC Company Detail
11.1.2 SFC Fluidics LLC Business Overview
11.1.3 SFC Fluidics LLC Traumatic Brain Injury Therapeutics Introduction
11.1.4 SFC Fluidics LLC Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.1.5 SFC Fluidics LLC Recent Development
11.2 Banayan Biomarkers Inc.
11.2.1 Banayan Biomarkers Inc. Company Detail
11.2.2 Banayan Biomarkers Inc. Business Overview
11.2.3 Banayan Biomarkers Inc. Traumatic Brain Injury Therapeutics Introduction
11.2.4 Banayan Biomarkers Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.2.5 Banayan Biomarkers Inc. Recent Development
11.3 BHR Pharma LLC
11.3.1 BHR Pharma LLC Company Detail
11.3.2 BHR Pharma LLC Business Overview
11.3.3 BHR Pharma LLC Traumatic Brain Injury Therapeutics Introduction
11.3.4 BHR Pharma LLC Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.3.5 BHR Pharma LLC Recent Development
11.4 Cerora Inc.
11.4.1 Cerora Inc. Company Detail
11.4.2 Cerora Inc. Business Overview
11.4.3 Cerora Inc. Traumatic Brain Injury Therapeutics Introduction
11.4.4 Cerora Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.4.5 Cerora Inc. Recent Development
11.5 ElMindA Ltd.
11.5.1 ElMindA Ltd. Company Detail
11.5.2 ElMindA Ltd. Business Overview
11.5.3 ElMindA Ltd. Traumatic Brain Injury Therapeutics Introduction
11.5.4 ElMindA Ltd. Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.5.5 ElMindA Ltd. Recent Development
11.6 Grace Laboratories LLC
11.6.1 Grace Laboratories LLC Company Detail
11.6.2 Grace Laboratories LLC Business Overview
11.6.3 Grace Laboratories LLC Traumatic Brain Injury Therapeutics Introduction
11.6.4 Grace Laboratories LLC Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.6.5 Grace Laboratories LLC Recent Development
11.7 KeyNeurotek Pharmaceuticals AG
11.7.1 KeyNeurotek Pharmaceuticals AG Company Detail
11.7.2 KeyNeurotek Pharmaceuticals AG Business Overview
11.7.3 KeyNeurotek Pharmaceuticals AG Traumatic Brain Injury Therapeutics Introduction
11.7.4 KeyNeurotek Pharmaceuticals AG Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.7.5 KeyNeurotek Pharmaceuticals AG Recent Development
11.8 Luoxis Diagnostics
11.8.1 Luoxis Diagnostics Company Detail
11.8.2 Luoxis Diagnostics Business Overview
11.8.3 Luoxis Diagnostics Traumatic Brain Injury Therapeutics Introduction
11.8.4 Luoxis Diagnostics Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.8.5 Luoxis Diagnostics Recent Development
11.9 Neuro Assessment Systems
11.9.1 Neuro Assessment Systems Company Detail
11.9.2 Neuro Assessment Systems Business Overview
11.9.3 Neuro Assessment Systems Traumatic Brain Injury Therapeutics Introduction
11.9.4 Neuro Assessment Systems Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.9.5 Neuro Assessment Systems Recent Development
11.10 Neurovive Pharmaceuticals AB
11.10.1 Neurovive Pharmaceuticals AB Company Detail
11.10.2 Neurovive Pharmaceuticals AB Business Overview
11.10.3 Neurovive Pharmaceuticals AB Traumatic Brain Injury Therapeutics Introduction
11.10.4 Neurovive Pharmaceuticals AB Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.10.5 Neurovive Pharmaceuticals AB Recent Development
11.11 Oxygen Biotherapeutics Inc.
11.11.1 Oxygen Biotherapeutics Inc. Company Detail
11.11.2 Oxygen Biotherapeutics Inc. Business Overview
11.11.3 Oxygen Biotherapeutics Inc. Traumatic Brain Injury Therapeutics Introduction
11.11.4 Oxygen Biotherapeutics Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.11.5 Oxygen Biotherapeutics Inc. Recent Development
11.12 Phlogistix LLC
11.12.1 Phlogistix LLC Company Detail
11.12.2 Phlogistix LLC Business Overview
11.12.3 Phlogistix LLC Traumatic Brain Injury Therapeutics Introduction
11.12.4 Phlogistix LLC Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.12.5 Phlogistix LLC Recent Development
11.13 Neurohealing Pharmaceuticals
11.13.1 Neurohealing Pharmaceuticals Company Detail
11.13.2 Neurohealing Pharmaceuticals Business Overview
11.13.3 Neurohealing Pharmaceuticals Traumatic Brain Injury Therapeutics Introduction
11.13.4 Neurohealing Pharmaceuticals Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.13.5 Neurohealing Pharmaceuticals Recent Development
11.14 Neuren Pharmaceuticals Ltd.
11.14.1 Neuren Pharmaceuticals Ltd. Company Detail
11.14.2 Neuren Pharmaceuticals Ltd. Business Overview
11.14.3 Neuren Pharmaceuticals Ltd. Traumatic Brain Injury Therapeutics Introduction
11.14.4 Neuren Pharmaceuticals Ltd. Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.14.5 Neuren Pharmaceuticals Ltd. Recent Development
11.15 Remedy Pharmaceuticals Inc.
11.15.1 Remedy Pharmaceuticals Inc. Company Detail
11.15.2 Remedy Pharmaceuticals Inc. Business Overview
11.15.3 Remedy Pharmaceuticals Inc. Traumatic Brain Injury Therapeutics Introduction
11.15.4 Remedy Pharmaceuticals Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.15.5 Remedy Pharmaceuticals Inc. Recent Development
11.16 Biodirection Inc.
11.16.1 Biodirection Inc. Company Detail
11.16.2 Biodirection Inc. Business Overview
11.16.3 Biodirection Inc. Traumatic Brain Injury Therapeutics Introduction
11.16.4 Biodirection Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.16.5 Biodirection Inc. Recent Development
11.17 Brainscope Company Inc.
11.17.1 Brainscope Company Inc. Company Detail
11.17.2 Brainscope Company Inc. Business Overview
11.17.3 Brainscope Company Inc. Traumatic Brain Injury Therapeutics Introduction
11.17.4 Brainscope Company Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.17.5 Brainscope Company Inc. Recent Development
11.18 TEVA Pharmaceutical Industries Ltd.
11.18.1 TEVA Pharmaceutical Industries Ltd. Company Detail
11.18.2 TEVA Pharmaceutical Industries Ltd. Business Overview
11.18.3 TEVA Pharmaceutical Industries Ltd. Traumatic Brain Injury Therapeutics Introduction
11.18.4 TEVA Pharmaceutical Industries Ltd. Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.18.5 TEVA Pharmaceutical Industries Ltd. Recent Development
11.19 Vasopharm
11.19.1 Vasopharm Company Detail
11.19.2 Vasopharm Business Overview
11.19.3 Vasopharm Traumatic Brain Injury Therapeutics Introduction
11.19.4 Vasopharm Revenue in Traumatic Brain Injury Therapeutics Business (2019-2024)
11.19.5 Vasopharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’